Authors: Garavaglia, Silvia¹; Perozzi, Silvia¹; Galeazzi, Luca²; Raffaelli, Nadia²; Rizzi, Menico¹

Source: FEBS Journal, Volume 276, Number 22, November 2009 , pp. 6615-6623(9)

Publisher: Wiley-Blackwell

Abstract:

The enzyme α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) is a zinc-dependent amidohydrolase that participates in picolinic acid (PA), quinolinic acid (QA) and NAD homeostasis. Indeed, the enzyme stands at a branch point of the tryptophan to NAD pathway, and determines the final fate of the amino acid, i.e. transformation into PA, complete oxidation through the citric acid cycle, or conversion into NAD through QA synthesis. Both PA and QA are key players in a number of physiological and pathological conditions, mainly affecting the central nervous system. As their relative concentrations must be tightly controlled, modulation of ACMSD activity appears to be a promising prospect for the treatment of neurological disorders, including cerebral malaria. Here we report the 2.0 Å resolution crystal structure of human ACMSD in complex with the glycolytic intermediate 1,3-dihydroxyacetonephosphate (DHAP), refined to an R-factor of 0.19. DHAP, which we discovered to be a potent enzyme inhibitor, resides in the ligand binding pocket with its phosphate moiety contacting the catalytically essential zinc ion through mediation of a solvent molecule. Arg47, Asp291 and Trp191 appear to be the key residues for DHAP recognition in human ACMSD. Ligand binding induces a significant conformational change affecting a strictly conserved Trp-Met couple, and we propose that these residues are involved in controlling ligand admission into ACMSD. Our data may be used for the design of inhibitors with potential medical interest, and suggest a regulatory link between de novo NAD biosynthesis and glycolysis.

Keywords: cerebral malaria; kynurenine pathway; metal-dependent amidohydrolase; NAD biosynthesis; neurological disorders

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1742-4658.2009.07372.x

Affiliations: 1:  DiSCAFF Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, University of Piemonte Orientale `A. Avogadro', Novara, Italy 2:  Department of Molecular Pathology and Innovative Therapies, Section of Biochemistry, Università Politecnica delle Marche, Ancona, Italy

Publication date: 2009-11-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Biology ,  Chemistry (General) ,  Biochemistry
• By this author: Garavaglia, Silvia ;  Perozzi, Silvia ;  Galeazzi, Luca ;  Raffaelli, Nadia ;  Rizzi, Menico

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers